Company / Operating Margin
Revolution Medicines, Inc. Operating Margin History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-4207.1%
FY2023
5-year range
-4207.1% / -108.1%
FY2020-FY2023
Trend
-1533.6%
vs FY2022
Sector context
#129 of 135
Health Care
What the data says
Operating Margin changed -1534% YoY in FY2023, a notable deviation from the 3-year average annual change of -542%.
Based on SEC 10-K filings.
-4207.1% in FY2023 with a 3-year CAGR of -4007.1%.
Declined from -108.1% to -4207.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -4007.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 135This company -4207.1% Sector average -774.4%
▼
-443.2% below sector average
Key checks
Key Insights
- In FY2023, operating margin decreased 1533.6% year-over-year.
- Currently 3432.7pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -4207.1% | -1533.6% |
| FY2022 | -257.5% | -138.1% |
| FY2021 | -108.1% | +45.9% |
| FY2020 | -200.0% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026